NEW YORK (TheStreet) -- RATINGS CHANGES
Ambit Biosciences (AMBI) was initiated with a sell rating at TheStreet Ratings.
C.R. Bard (BCR - Get Report) was downgraded at Barclays to equal weight from overweight. Pressure on company due to its exposure to the peripheral vascular space, which is affected by Medtronic (MDT)/Covidien (COV) deal, Barclays said.(BEN) was upgraded at Goldman Sachs to buy from neutral. Better flow trends are being driven by emerging markets, and recent underperformance offers a cheap entry point, Goldman said. GNC (GNC) was downgraded at J.P. Morgan to neutral. Company is seeing slower sales trends, and the CFO has left, J.P. Morgan said. Gap (GPS - Get Report) was upgraded at Canaccord Genuity to buy from hold. Twelve-month price target is $51. Company can continue to expand margins, Canaccord Genuity said. Medtronic was upgraded at Barclays to overweight from equal weight. Driven by potential benefits from acquisition of Covidien, Barclays said. Twelve-month price target is $73. (NRT) was downgraded to hold at TheStreet Ratings. Sunpower (SPWR) was downgraded at J.P. Morgan to neutral. Valuation call, as the stock is up 35% year to date, J.P. Morgan said. Twelve-month price target is $40. Tyson Foods (TSN) upgraded at BMO Capital to outperform. Higher margins create opportunities for realized earnings potential in Hillshire and accelerated repaying of debts, BMO Capital said. Twelve-month price target is $43. Walgreen (WAG) was upgraded at Barclays to overweight from equal weight. Driven by reducing expenses and optimizing capital structure, Barclays said. Twelve-month price target is $92. Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here. Follow TheStreet on Twitter and become a fan on Facebook. Citigroup Looks Like a Smart Hedge as Interest Rates Remain Low United Leads in China, but American and Delta Want Bigger Shares
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts